Skip to main content
. 2020 Dec 3;10(12):2287. doi: 10.3390/ani10122287

Table 4.

Effect of dietary C. butyricum on short-chain fatty acids in colonic chyme (mean ± SE 2, µmol/g).

Item Dietary Treatments 1 p-Value
CON AGP CBN CBH
Acetic acid 55.66 ± 5.10 a 60.78 ± 3.38 a,b 68.23 ± 1.70 b,c 71.66 ± 1.57 c 0.008
Propionic acid 19.90 ± 0.80 a 21.37 ± 0.72 a 21.82 ± 1.31a 24.90 ± 1.16 b 0.017
Butyric acid 7.87 ± 0.93 a 7.35 ± 0.38 a 7.81 ± 0.61a 10.86 ± 1.28 b 0.021
Isobutyric acid 0.90 ± 0.07 b 0.40 ± 0.06 a 0.55 ± 0.07 a 0.80 ± 0.08 b <0.01
Valeric acid 1.97 ± 0.26 b 0.99 ± 0.09 a 1.16 ± 0.22 a 2.16 ± 0.19 b <0.01
Isovaleric acid 1.17 ± 0.09 b 0.61 ± 0.05 a 0.75 ± 0.11 a 1.07 ± 0.09 b <0.01
Total short chain fatty acids 87.47 ± 8.06 a 91.50 ± 4.46 a 100.32 ± 2.40 a,b 111.45 ± 9.43 b 0.006

a–c Different superscripts within a row indicate a significant difference (p < 0.05). 1 Dietary treatments: CON = basal diet; AGP = basal diet supplemented with 0.075 g/kg chlortetracycline, 0.055 g/kg kitasamycin, and 0.01 g/kg virginiamycin; CBN = basal diet supplemented with 2.5 × 108 CFU/kg C. butyricum; CBH = basal diet supplemented with 2.5 × 109 CFU/kg C. butyricum. 2 SE: standard error of the mean. Each treatment group contains six replicates (n = 6), and each replicate includes one piglet.